Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TG-1000 for acute uncomplicated influenza (Phase III, randomized, placebo-controlled)
ChiCTR2500096796Phase 3Completed
- Sponsor
- No. 28, Qiaozhong Middle Road, Liwan District, Guangzhou
- Start
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in influenza comparing TG-1000 with Placebo (2 arms). Primary endpoint: Time to alleviation of all influenza-related symptoms. Started Feb 2025; status: completed.
02
Drugs
TG-1000
03
Conditions
influenza
Beyond the preview
Go deeper on ChiCTR2500096796.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500096796.